VEGFA and neoplasm: These differences may be attributed to apatinib, which inhibits the over expression of VEGF in tumor cells induced by embolization after TACE, thereby blocking the migration and proliferation of vascular endothelial cells, decreasing tumor microvessel density, and inhibiting tumor growth.